Shared aggressive signature across all PABC cases, marked by increased proliferation and impaired DNA repair. »
06/24/26

Elevated TGFB2 expression associated with metabolic reprogramming and poorer clinical outcomes. »
06/24/26

Time to disease progression generally longer in patients with homologous recombination repair gene mutations. »
06/25/26

Liver predominant site of metastases. »
06/26/26

228-CpG signature showed strong association with survival. »
06/26/26

Non-advanced SM (vs. advanced) remained independently associated with improved OS. »
06/26/26

NPs also reduced migration potential of CRC cells. »
06/27/26

Gene expression analysis revealed identical molecular responses to Am80 and ATRA. »
06/27/26

Knockdown of SOX9 recapitulated functional effect of HES1 inhibition. »
06/27/26

Anorectum was predominant site. »
06/29/26